MedTrace Logo

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

NCT06693622 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 556

Last updated 2024-11-18

No results posted yet for this study

Summary

This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.

Conditions

  • Gastro Esophageal Reflux Disease
  • Barrett Esophagus

Interventions

BEHAVIORAL

Patient survey

To assess patient preferences and barriers for attributes of BE/EAC screening modalities patients will complete a survey evaluating 5 domains: benefit of detection (sensitivity), convenience (time, setting), screening related physical harms (procedural discomfort), and financial harms. Prior to distribution, the survey will be refined and pretested among a sample of 5 patients.

Sponsors & Collaborators

  • American Society for Gastrointestinal Endoscopy

    collaborator OTHER

  • University of California, Los Angeles

    collaborator OTHER

  • University of Michigan

    collaborator OTHER

  • Exact Sciences Corporation

    collaborator INDUSTRY

  • VA Medical Center-West Los Angeles

    collaborator FED

  • University of Texas Southwestern Medical Center

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Sachin Wani, MD · University of Colorado, Denver

  • Jennifer Kolb, MD, MS · University of California, Los Angeles

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2029-03-01
Completion
2029-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06693622 on ClinicalTrials.gov